152 related articles for article (PubMed ID: 11549576)
21. A handcrafted tissue microarray for a matrix arrangement of tissue samples.
Sampaio JP; Cavalcante JR; Furtado FN; Lima-Júnior RC; Ribeiro RA; Almeida PR
J Pharmacol Toxicol Methods; 2014; 70(1):70-2. PubMed ID: 24879941
[TBL] [Abstract][Full Text] [Related]
22. Multifocal high grade prostatic intraepithelial neoplasia is a risk factor for subsequent prostate cancer.
Lee MC; Moussa AS; Yu C; Kattan MW; Magi-Galluzzi C; Jones JS
J Urol; 2010 Nov; 184(5):1958-62. PubMed ID: 20846692
[TBL] [Abstract][Full Text] [Related]
23. Ability to predict metastasis based on pathology findings and alterations in nuclear structure of normal-appearing and cancer peripheral zone epithelium in the prostate.
Veltri RW; Khan MA; Miller MC; Epstein JI; Mangold LA; Walsh PC; Partin AW
Clin Cancer Res; 2004 May; 10(10):3465-73. PubMed ID: 15161703
[TBL] [Abstract][Full Text] [Related]
24. From gene to clinic: TMA-based clinical validation of molecular markers in prostate cancer.
Schlomm T; Chun FKh; Erbersdobler A
Methods Mol Biol; 2010; 664():177-89. PubMed ID: 20690063
[TBL] [Abstract][Full Text] [Related]
25. A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray.
Hawley S; Fazli L; McKenney JK; Simko J; Troyer D; Nicolas M; Newcomb LF; Cowan JE; Crouch L; Ferrari M; Hernandez J; Hurtado-Coll A; Kuchinsky K; Liew J; Mendez-Meza R; Smith E; Tenggara I; Zhang X; Carroll PR; Chan JM; Gleave M; Lance R; Lin DW; Nelson PS; Thompson IM; Feng Z; True LD; Brooks JD
Adv Anat Pathol; 2013 Jan; 20(1):39-44. PubMed ID: 23232570
[TBL] [Abstract][Full Text] [Related]
26. The tissue microarray object model: a data model for storage, analysis, and exchange of tissue microarray experimental data.
Lee HW; Park YR; Sim J; Park RW; Kim WH; Kim JH
Arch Pathol Lab Med; 2006 Jul; 130(7):1004-13. PubMed ID: 16831026
[TBL] [Abstract][Full Text] [Related]
27. Can molecular markers stratify the diagnostic value of high-grade prostatic intraepithelial neoplasia?
Hailemariam S; Vosbeck J; Cathomas G; Zlobec I; Mattarelli G; Eichenberger T; Zellweger T; Bachmann A; Gasser TC; Bubendorf L
Hum Pathol; 2011 May; 42(5):702-9. PubMed ID: 21237492
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of alpha-methylacyl-coA racemase among men with high grade prostatic intraepithelial neoplasia in prostate biopsies.
Stewart J; Fleshner N; Cole H; Toi A; Sweet J
J Urol; 2008 May; 179(5):1751-5; discussion 1755. PubMed ID: 18343427
[TBL] [Abstract][Full Text] [Related]
29. The role of tissue microarrays in prostate cancer biomarker discovery.
Datta MW; True LD; Nelson PS; Amin MB
Adv Anat Pathol; 2007 Nov; 14(6):408-18. PubMed ID: 18049130
[TBL] [Abstract][Full Text] [Related]
30. Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH database.
Scales CD; Presti JC; Kane CJ; Terris MK; Aronson WJ; Amling CL; Freedland SJ;
J Urol; 2007 Oct; 178(4 Pt 1):1249-52. PubMed ID: 17698131
[TBL] [Abstract][Full Text] [Related]
31. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.
Guo Y; Sklar GN; Borkowski A; Kyprianou N
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2269-74. PubMed ID: 9815624
[TBL] [Abstract][Full Text] [Related]
32. Prediction of extraprostatic extension in the neurovascular bundle based on prostate needle biopsy pathology, serum prostate specific antigen and digital rectal examination.
Tsuzuki T; Hernandez DJ; Aydin H; Trock B; Walsh PC; Epstein JI
J Urol; 2005 Feb; 173(2):450-3. PubMed ID: 15643200
[TBL] [Abstract][Full Text] [Related]
33. Tissue microarrays in clinical urology--technical considerations.
Kramer MW; Merseburger AS; Hennenlotter J; Kuczyk M
Scand J Urol Nephrol; 2007; 41(6):478-84. PubMed ID: 17907050
[TBL] [Abstract][Full Text] [Related]
34. Development of an integrated prostate cancer research information system.
Oh WK; Hayes J; Evan C; Manola J; George DJ; Waldron H; Donovan M; Varner J; Orechia J; Katcher B; Lu D; Nevins A; Wright RL; Tormey L; Talcott J; Rubin MA; Loda M; Sellers WR; Richie JP; Kantoff PW; Weeks J
Clin Genitourin Cancer; 2006 Jun; 5(1):61-6. PubMed ID: 16859581
[TBL] [Abstract][Full Text] [Related]
35. Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies.
Bubendorf L; Nocito A; Moch H; Sauter G
J Pathol; 2001 Sep; 195(1):72-9. PubMed ID: 11568893
[TBL] [Abstract][Full Text] [Related]
36. The role of biopsy pathology, quantitative nuclear morphometry, and biomarkers in the preoperative prediction of prostate cancer staging and prognosis.
Veltri RW; O'Dowd GJ; Orozco R; Miller MC
Semin Urol Oncol; 1998 Aug; 16(3):106-17. PubMed ID: 9741414
[TBL] [Abstract][Full Text] [Related]
37. The development and validation of the Virtual Tissue Matrix, a software application that facilitates the review of tissue microarrays on line.
Conway CM; O'Shea D; O'Brien S; Lawler DK; Dodrill GD; O'Grady A; Barrett H; Gulmann C; O'Driscoll L; Gallagher WM; Kay EW; O'Shea DG
BMC Bioinformatics; 2006 May; 7():256. PubMed ID: 16707006
[TBL] [Abstract][Full Text] [Related]
38. Tissue-marking scheme for a cost-effective extended prostate biopsy protocol.
Firoozi F; Nazeer T; Fisher HA; Kaufman RP; White MD; Mian BM
Urol Oncol; 2009; 27(1):21-5. PubMed ID: 18367125
[TBL] [Abstract][Full Text] [Related]
39. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
[TBL] [Abstract][Full Text] [Related]
40. Digital microscopy for boosting database integration and analysis in TMA studies.
Krenacs T; Ficsor L; Varga SV; Angeli V; Molnar B
Methods Mol Biol; 2010; 664():163-75. PubMed ID: 20690062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
